Hikma Pharmaceuticals PLC 2023 Annual Report with Sustainability Disclosures
Company: Hikma Pharmaceuticals PLC
Sector: Manufacturing
Country: United Kingdom
Year: 2023
Type: Annual Report with Sustainability Disclosures
Pages: 208
The report records a strong 2023 performance, with Group revenue of $2,875m and a 15% reduction in market-based Scope 1 and 2 emissions against the 2020 baseline. It expands environmental disclosure through a 2023 Scope 3 total of 925,152 tCO2e and describes GHG Protocol-aligned reporting and external verification. The report also highlights a global workforce of 9,100 employees, 35% women across the Group and 42% women on the Board. Sustainability governance is assigned overarching oversight by the Board, supported by executive committees and dedicated ESG committees.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.